<DOC>
	<DOCNO>NCT00649909</DOCNO>
	<brief_summary>The efficacy low dose aspirin appear substantially low diabetic patient , compare patient without diabetes . We perform observational study follow patient uncontrolled type 2 Diabetes Mellitus low response aspirin ( Aspirin Resistance ) , period 6 month diabetic clinic . Our hypothesis glucose control improve response aspirin patient .</brief_summary>
	<brief_title>Effect Glucose Control Response Aspirin Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Inclusion Criteria 1 . Type 2 DM . 2 . Patients take aspirin . 3 . Antecubital forearm vein allow technically good sample platelet study . 4 . Reduced Laboratory response aspirin . 5 . HbA1c &gt; 8 % 6 . The physician decides indication glucose control . 1 . Acute ischemic stroke , acute coronary syndrome , ( myocardial infarction unstable angina pectoris ) , revascularization PCI bypass surgery within last 6 month . 2 . Acute kidney disease chronic kidney disease creatinine clearance &lt; 30 . 3 . Acute liver disease chronic liver disease severe liver impairment . 4 . Need treatment anticoagulant , clopidogrel , NSAID 's , thiazolidinediones . 5 . Thrombocytopenia ( platelet count &lt; 150 x 109/L )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Type II</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Resistance</keyword>
</DOC>